Univercells

Univercells is a medical engineering company having developed technologies aiming at reducing the cost of vaccines and biologics by significant factors. Amongst others, it has attracted the attention of the Bill & Melinda Gates Foundation and been granted important subsidies. The Series B was led by American and Korean professional

YUST

YUST has created a fast-growing and innovative smart living concept with strong operational results for the first residence in Antwerp. A series of other sites are scheduled to be opened in the next two years (sites are secured). YUST targets young urban individuals and will combine accommodation with trendy services:

Graftys

Graftys, taken over in 2017 by Enrico Bastianelli (ex-CEO of Bone Therapeutics), active in medtech’s market, is one of the world leaders (alongside BONESUPPORT AB, listed on the NASDAQ in Stockholm), in synthetic resorbable orthopaedic cements, with a pipeline of 2 marketed products (registered in 27 countries). Following to the

Trigrr (ex Bizmotica)

The company developed over 8-years a powerful code which enables to link audio, video, electricity, heating, lighting, digital signage, security, … -related technologies. The company is now ready to deploy the sales of its software solution through specialised system integrators for B2B (eg. hotels, event centers, offices) & B2C (residential).

Vivalto Home Bond

This company offers independent, dependent or disoriented elderly people a network of care/nursing homes or residences for assisted living. Company is now looking for additional means to strengthen its sustainable roadmap of expansion. Website: https://www.vivaltohome.com/

Lawbox

Lawbox is a legaltech startup which has developed a platform allowing to automate the writing of contracts and the usage of other documents and templates. It sells contracts and subscriptions to its database through its website. Webstie: https://www.lawbox.be

BCI Pharma SA

BCI Pharma is a company existing for 5 years in Montpellier, France. It has been relocated partly to Liège following a 3MM capital increase led by TheClubDeal.It has developed proofs of concepts in Biotech research on neuropathic pains, on a medical development articulated on kinase inhibitors, highly potent and targeted

3D-Side

3D-Side is a company offering comprehensive assistance in neuro- and orthopaedic surgery, from 3D imaging to 3D printing and related ERP. Website:  https://www.3dside.eu/

dFakto

TheClubDeal has closed a €2m capital increase in dFakto, a Belgian software company. The company brings unique solutions, in Belgium and other countries, to private and public institutions, to help the management be even more efficient with the support of data-driven decisions. The new capital will be used, among others,

Deal Status

Investment Type